Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
M.D. Anderson Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
University of Nebraska
Zhejiang University
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
Azienda Ospedaliera di Padova
Instituto do Cancer do Estado de São Paulo
Columbia University
Nanjing First Hospital, Nanjing Medical University
Cedars-Sinai Medical Center
Rutgers, The State University of New Jersey
Beijing Friendship Hospital
Istituti Clinici Scientifici Maugeri SpA
M.D. Anderson Cancer Center
Institut Bergonié
Dana-Farber Cancer Institute
Centre Hospitalier Universitaire de Nice
Aventura Hospital and Medical Center
AHS Cancer Control Alberta
Memorial Sloan Kettering Cancer Center
Stanford University
University of Chicago
Rutgers, The State University of New Jersey